BioPharmSignal logoBioPharmSignal

Biotech News

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Avidity Biosciences (RNA)Avidity BiosciencesConference / presentation

RNA (RNA) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is rna.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

RNAAvidity Biosciences2025-10-16 13:00 EST

Avidity Biosciences to Participate in Upcoming Investor Conference

RNAAvidity Biosciences2026-02-27 14:16 EST

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

View all latest news

Avidity Biosciences

Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform. Its story is built around targeted RNA delivery and disease-specific programs.

Recent company news

RNAAvidity Biosciences2026-02-27 14:16 EST

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

RNAAvidity Biosciences2026-02-26 21:02 EST

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

RNAAvidity Biosciences2026-02-23 13:00 EST

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders

RNAAvidity Biosciences2026-02-18 22:00 EST

The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1

RNAAvidity Biosciences2026-02-03 02:44 EST

Avidity Biosciences Announces Expected Record Date for Spin-Off

Stock data

Close
12.11 USD
Market cap
209.54M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States